Stephen C. Hadler

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Respiratory Illness Caused by Corynebacterium diphtheriae and C. ulcerans, and Use of Diphtheria Antitoxin in the United States, 1996–2018”.

Respiratory Illness Caused by Corynebacterium diphtheriae and C. ulcerans, and Use of Diphtheria Antitoxin in the United States, 1996–2018

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1218

N/A

0DataRank · unranked

28 citations

Anna M. Acosta, Pamela K. Cassiday, Stephen C. Hadler, Susan Hariri, Tejpratap Tiwari +1 more

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7027e2

N/A

0DataRank · unranked

602 citations

Megan Wallace, Stephen C. Hadler, Gayle Langley, John R. Su, Matthew E. Oster +15 more

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7032e4

N/A

0DataRank · unranked

215 citations

Stephen C. Hadler, Danielle Moulia, Tom T. Shimabukuro, John R. Su, Naomi K. Tepper +17 more

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7017e4

N/A

0DataRank · unranked

187 citations

John R. Su, Karen R. Broder, Alice Guh, Julia W. Gargano, Megan Wallace +12 more

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7045e1

N/A

0DataRank · unranked

173 citations

Danielle Moulia, Jennifer P. Collins, Stephen C. Hadler, Jefferson M. Jones, Sujan Reddy +12 more

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7009e4

N/A

0DataRank · unranked

171 citations

Julia W. Gargano, Heather M. Scobie, Megan Wallace, Stephen C. Hadler, Jessica W. T. Leung +12 more

Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7038e2

N/A

0DataRank · unranked

41 citations

Julia W. Gargano, Danielle Moulia, Megan Wallace, Hannah G. Rosenblum, Amy Blain +14 more

Ancillary benefits of seasonal influenza vaccination in middle-income countries

Vaccine(2021)10.1016/j.vaccine.2021.02.048

N/A

0DataRank · unranked

0 citations

Susan Y. Chu, Eduardo Azziz‐Baumgartner, Kathryn E. Lafond, Margaret McCarron, Stephen C. Hadler +4 more

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7103a4

N/A

0DataRank · unranked

101 citations

Megan Wallace, Isaac See, Sarah Mbaeyi, Monica Godfrey, Stephen C. Hadler +19 more

A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States

Vaccine(2023)10.1016/j.vaccine.2023.07.037

N/A

0DataRank · unranked

21 citations

Hannah G. Rosenblum, Danielle Moulia, Karen R. Broder, Tom T. Shimabukuro, Christopher A. Taylor +7 more

Supporting National Immunization Technical Advisory Groups (NITAGs) in development of evidence-based vaccine recommendations and NITAG assessments – New tools and approaches

Vaccine(2024)10.1016/j.vaccine.2024.01.035

N/A

0DataRank · unranked

9 citations

Abigail Shefer, Kathleen F. Cavallaro, Malembe Ebama, Catherine B. Tencza, Erin Kennedy +5 more